QUOTE AND NEWS
Benzinga  Jul 27  Comment 
One bull still stands for Community Health Systems (NYSE: CYH), even after management’s preview of second-quarter earnings on Wednesday shocked and disappointed most investors. The news also came just a day after HCA Healthcare Inc (NYSE: HCA)...
TechCrunch  Apr 21  Comment 
 Several teams of researchers at USC have joined forces for a study aimed at detecting vital signs to help stem conflicts in couples before they occur. Couples were brought into the lab, equipped with wearable sensors, given smartphones for...
MedPage Today  Mar 20  Comment 
(MedPage Today) -- Case Findings: A 29-year-old male with a history of autism, seizures, headaches, and Parkinsonism presents with a 5-day history of developing nodular erythematous lesions on the trunk and limbs. He also has fever and a headache,...
MarketWatch  Mar 13  Comment 
Every major vital sign of labor market health suggests U.S. “job growth is accelerating,” according to a survey that tracks employment.
Forbes  Feb 21  Comment 
What if every one of your vital signs that have been recorded, all the medicines taken, information associated with every doctor’s visit, illness, operations and more could be efficiently and accurately captured?
Forbes  Aug 24  Comment 
Imagine if you could track everything from your calorie intake to your vital signs through a device no wider than your ring finger? If a recent crowdfunding campaign is any indication, this may soon become a reality, one that will reshape the...
MarketWatch  May 22  Comment 
Wall Street has gone from worrying the economy is not strong enough to thinking it might be too strong. Here’s why.




 
TOP CONTRIBUTORS

Headquartered in Totowa, New Jersey, Vital Signs (VITL) is a leading designer, manufacturer, and marketer of airway management products for the anesthesia, respiratory/critical care, and sleep disorder markets. The company sells its products in more than 70 countries globally. The company provides the broadest single-patient use anesthesia and respiratory/critical care product lines in the industry. Beginning in 1997 with the equity interest in Breas Medical AB, the company has expanded its focus to the sleep therapy and personal ventilation markets. It also delivers technology services to FDA regulated companies. The company derives revenues principally from five segments: Anesthesia, Respiratory/Critical Care, Sleep Disorder, Pharmaceutical Technology Services, and Interventional Cardiology/Radiology. The Pharmaceutical Technology Services segment was classified, as of FQ107, as a discontinued operation, with VITL expecting the unit to be sold. However, as of FQ407, the segment has been reclassified to continuing operations since the company received no acceptable offers for sale. The Interventional Cardiology/Radiology business operates primarily as Thomas Medical. It was earlier included in the anesthesia segment, but is now segregated. The company has been operating in the Anesthesia market for 33 years and provides single-patient use anesthesia breathing circuits, face masks, and general anesthesia products. These products comprise air-filled cushion face masks, breathing circuits and temperature monitoring probes, single limb breathing circuits, single use airway devices, and fiberoptic laryngoscope systems. The Respiratory/Critical Care segment provides arterial blood gas syringes and kits, manual resuscitators, and blood pressure cuffs. The company also distributes critical care equipment kits and modules, which are color coded to allow emergency room workers to quickly and accurately determine the proper equipment size to use with pediatric patients. The Sleep Disorder segment offers sleep disorder/personal ventilation products that include continuous positive airway pressure flow generators, humidification systems, sleep disorder home screening devices, life support ventilator, and other ventilators. This segment also provides diagnostic and therapeutic services for sleep disorders. The Pharmaceutical Technology Services segment offers consulting services to medical device, diagnostic, and biotechnology companies, thereby helping the companies to develop and validate systems and processes for their manufacturing, infrastructure, research and development, and laboratory and quality assurance departments. In fiscal 2007 (fiscal year ends September) Anesthesia, Respiratory/Critical Care, Sleep Disorder, Pharmaceutical Technology Services, and Interventional Cardiology/Radiology contributed 36%, 23%, 21%, 6%, and 14% of revenues, respectively.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki